Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

bc-serapro Press Releases

  + XML/RSS  



By Derrick Bosket
Cutera, Inc. previously reported U.S. Food and Drug Administration (FDA) 510(k) clearance for its GenesisPlus.

By Derrick Bosket
As a New technology for early detection, minimally-invasive BC-SeraPro Test from Power3 should participate favorably in the aforementioned mammogram market .

By Hanson
The company has also established over 1,100 city specific sites within the US, allowing Crown Equity Holdings Inc. to publish its news and information globally or geographically.

By Hanson
PWRM delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii.

By Hanson
Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.

By Hanson
PWRM BC-SeraPro was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.BC-SeraPro™ is an ideal diagnostic test to evaluate breast cancer abnormalities

By Justin Handy
KERX, a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases.

By Hanson
Power3 Medical Products (OTCBB: PWRM.OB) BC-SeraPro™ was developed and its performance characteristics determined by the Power3 Medical Products Laboratories.

By Hanson
With these results, PWRM’s NuroPro now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment

By Hanson
The Company is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory.

By Hanson
BC-SeraPro™ could detect the disease at a point when treatment is more effective, less expensive, or both.

By Hanson
PWRM’s NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease.

By Hanson
Power3 Medical Products Inc., (OTCBB: PWRM.OB) strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies

By Hanson
PWRM’s NuroPro Blood Test is diagnostic tool for the early detection of Neurodegenerative diseases.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share